RECORD TAVR REGISTRY: Prospective, Multi-Center Registry of Real World Chinese Patients Undergoing Transcatheter Aortic Valve Replacement
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
The purpose of this prospective multi-center, observational registry in China is to collect clinical baseline, procedural, and follow-up data of all patients treated with TAVR in China and to evaluate short-, mid-, and long-term clinical outcome data of all post-marketing transcatheter valves. Each center will collect baseline and procedural data as well as clinical outcomes for up to 10 years.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients with aortic valve disease are evaluated by the cardiac team and indicate TAVR therapy
• Patients who understand the purpose of this study, voluntarily participate in the trial and sign the informed consent form
Locations
Other Locations
China
Ling Tao
RECRUITING
Xi'an
Contact Information
Primary
Rutao Wang, M.D, Ph.D
rutaowang@qq.com
+86-15091095796
Backup
Ruining Zhang, BSc
ruining-zhang@qq.com
+86-15802990370
Time Frame
Start Date: 2023-10-30
Estimated Completion Date: 2034-01-01
Participants
Target number of participants: 3000
Related Therapeutic Areas
Sponsors
Leads: Xijing Hospital